| 17beta-estradiol | increases expression | ISO | RGD:1319453 | 6480464 | Estradiol results in increased expression of AGPAT2 mRNA | CTD | PMID:23019147 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1319453 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGPAT2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1319454 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AGPAT2 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1319453 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of AGPAT2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of AGPAT2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1319453 | 6480464 | Tetrachlorodibenzodioxin affects the expression of AGPAT2 mRNA | CTD | PMID:22298810 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1319453 | 6480464 | decitabine results in increased expression of AGPAT2 mRNA | CTD | PMID:17908484 |
| aflatoxin B1 | affects expression | ISO | RGD:1319453 | 6480464 | Aflatoxin B1 affects the expression of AGPAT2 protein | CTD | PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319454 | 6480464 | Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | CTD | PMID:21715664 PMID:19770486 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319454 | 6480464 | Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | CTD | PMID:19770486 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319454 | 6480464 | Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | CTD | PMID:19770486 PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1319454 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of AGPAT2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319454 | 6480464 | Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1319453 | 6480464 | Benzo(a)pyrene results in decreased expression of AGPAT2 mRNA | CTD | PMID:20106945 |
| cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of AGPAT2 promoter | CTD | PMID:22457795 |
| capecitabine | increases response to substance | ISO | RGD:1319453 | 6480464 | AGPAT2 protein results in increased susceptibility to capecitabine | CTD | PMID:16734730 |
| ciglitazone | increases expression | ISO | RGD:1319454 | 6480464 | ciglitazone results in increased expression of AGPAT2 mRNA | CTD | PMID:16847310 |
| clofibric acid | affects expression | EXP | | 6480464 | Clofibric Acid affects the expression of AGPAT2 mRNA | CTD | PMID:17602206 |
| copper(2+) sulfate | increases expression | ISO | RGD:1319453 | 6480464 | Copper Sulfate results in increased expression of AGPAT2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | decreases expression | ISO | RGD:1319453 | 6480464 | Cyclosporine results in decreased expression of AGPAT2 mRNA | CTD | PMID:20106945 |
| diarsenic trioxide | decreases response to substance | ISO | RGD:1319453 | 6480464 | AGPAT2 protein results in decreased susceptibility to arsenic trioxide | CTD | PMID:20707922 |
| elemental selenium | multiple interactions | ISO | RGD:1319453 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA | CTD | PMID:19244175 |
| elemental selenium | increases expression | ISO | RGD:1319453 | 6480464 | Selenium results in increased expression of AGPAT2 mRNA | CTD | PMID:19244175 |
| ethanol | increases expression | ISO | RGD:1319454 | 6480464 | Ethanol results in increased expression of AGPAT2 mRNA | CTD | PMID:19167417 |
| genistein | increases expression | ISO | RGD:1319453 | 6480464 | Genistein results in increased expression of AGPAT2 mRNA | CTD | PMID:23019147 |
| hydralazine | multiple interactions | ISO | RGD:1319453 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA | CTD | PMID:17183730 |
| paracetamol | affects expression | ISO | RGD:1319454 | 6480464 | Acetaminophen affects the expression of AGPAT2 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1319453 | 6480464 | Acetaminophen results in decreased expression of AGPAT2 mRNA | CTD | PMID:22230336 |
| perfluorooctanoic acid | affects expression | ISO | RGD:1319454 | 6480464 | perfluorooctanoic acid affects the expression of AGPAT2 mRNA | CTD | PMID:18281256 |
| pirinixic acid | increases expression | ISO | RGD:1319454 | 6480464 | pirinixic acid results in increased expression of AGPAT2 mRNA | CTD | PMID:18301758 |
| propiconazole | decreases expression | ISO | RGD:1319454 | 6480464 | propiconazole results in decreased expression of AGPAT2 mRNA | CTD | PMID:21278054 |
| selenium atom | multiple interactions | ISO | RGD:1319453 | 6480464 | [Selenium co-treated with Vitamin E] results in decreased expression of AGPAT2 mRNA | CTD | PMID:19244175 |
| selenium atom | increases expression | ISO | RGD:1319453 | 6480464 | Selenium results in increased expression of AGPAT2 mRNA | CTD | PMID:19244175 |
| tetracycline | increases expression | ISO | RGD:1319454 | 6480464 | Tetracycline results in increased expression of AGPAT2 mRNA | CTD | PMID:16917069 |
| valproic acid | multiple interactions | ISO | RGD:1319453 | 6480464 | [Hydralazine co-treated with Valproic Acid] results in decreased expression of AGPAT2 mRNA | CTD | PMID:17183730 |